ArticleOncology letters2017

TCN, an AKT inhibitor, exhibits potent antitumor activity and enhances radiosensitivity in hypoxic esophageal squamous cell carcinoma

Qing Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.